ENDPOINTS NEWS23h
Health­care shake­up hits Wash­ing­ton, with cuts at CDC, NIH and oth­er agen­cies
The Trump administration’s effort to remake the federal workforce swept through US healthcare agencies on Friday, with wide ...
ENDPOINTS NEWS21h
Lil­ly’s ear­ly blad­der can­cer da­ta hint at safe­ty edge over J&J’s Balver­sa
Eli Lilly shares first human trial results for LOXO-435, a selective FGFR3 inhibitor for bladder cancer, showing 41% response ...
ENDPOINTS NEWS10h
Up­dates from Wash­ing­ton; A trio of Big Phar­ma deals; What do re­cent share buy­backs mean for M&A?; and more
Welcome back to Endpoints Weekly. Grab a cup of Saturday morning coffee and let’s dive straight into the news — it was a busy week!
ENDPOINTS NEWS18h
GSK fol­lows Pfiz­er in meningo­coc­cal vac­cine race with new FDA nod
GSK has snagged FDA approval for its 5-in-1 meningococcal vaccine, propelling it to a familiar position: rivaling Pfizer.